PDS Biotechnology Corporation (PDSB) Stock Price

0.6496 ▼ -0.0404 (-5.86%)
Open: 0.7088 Vol: 463.59K Day's range: 0.6301 - 0.7198 Mar 18, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PDSB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 0.65▼ 0.65▼ 0.65▼ 0.65▼ 0.66▼
MA10 0.67▼ 0.68▼ 0.68▼ 0.66▼ 0.74▼
MA20 0.69▼ 0.68▼ 0.67▼ 0.67▼ 0.81▼
MA50 0.67▼ 0.67▼ 0.67▼ 0.78▼ 1.06▼
MA100 0.67▼ 0.67▼ 0.67▼ 0.83▼ 1.81▼
MA200 0.67▼ 0.67▼ 0.69▼ 1.03▼ 3.79▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.007▼ -0.006▼ -0.004▼ 0.005▲ -0.006▼
RSI 36.717▼ 41.747▼ 44.505▼ 42.505▼ 36.185▼
STOCH 6.149▼ 4.195▼ 10.091▼ 32.557     8.696▼
WILL %R -95.072▼ -95.918▼ -95.918▼ -78.763▼ -91.181▼
CCI -78.637     -90.445     -60.187     -13.107     -73.915    
Latest Filters Detected On PDSB
MA $PDSB Price Crossed Below MA(26) Set Alert
MA $PDSB Price Crossed Below MA(13) Set Alert
MA $PDSB Price Crossed Below MA(7) Set Alert
▲ GAP $PDSB Open Gap Up %2 Set Alert
CDL $PDSB Engulfing Candlestick Pattern Detected Set Alert
PDS Biotechnology Corporation News
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Sunday, March 01, 2026 04:00 PM
Dr. Frank Bedu-Addo has served as President, CEO and a director of PDS Biotechnology Corporation since its inception in 2005. Dr. Bedu-Addo is a veteran biotech executive with experience successfully ...
PDS Biotech Announces Adoption of Amended Protocol for Phase 3 VERSATILE-003 Trial Incorporating Progression Free Survival (PFS) as Primary Endpoint for Interim Analysis and ...
Friday, February 20, 2026 12:30 AM
PRINCETON, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101
Thursday, January 22, 2026 12:46 AM
PRINCETON, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
PDSB historical stock data
date open high low close volume
18/03/26 0.7088 0.7198 0.6301 0.6496 463,592
17/03/26 0.67 0.7349 0.6331 0.69 1,179,752
16/03/26 0.6518 0.6699 0.6296 0.6327 133,998
13/03/26 0.645 0.6821 0.6266 0.631 182,791
12/03/26 0.68 0.68 0.6407 0.654 200,205
11/03/26 0.6831 0.6875 0.6652 0.6847 114,350
10/03/26 0.69 0.698 0.671 0.6868 171,965
09/03/26 0.645 0.6914 0.6398 0.6851 266,781
06/03/26 0.65 0.6788 0.6304 0.6729 199,784
05/03/26 0.6861 0.6868 0.6423 0.6604 253,966
Quote Details
52wk Low:0.601
52wk High:1.915
Vol:463.59K
Avg Vol(3m):10.3M
1Y Chng:-38.13%
1M Chng:-11.03%
Add to Watch List
More Information
Index US Composite
Market Cap. 37.76M